APP Pharmaceuticals (APPX) Reports Slightly Higher Q2 Earnings; Issues Soft FY08 Guidance
More News related to APPX
- APP Pharmaceuticals (APPX) Reports Slightly Higher Q2 Earnings; Issues Soft FY08 Guidance
- Unusual 11 Mid-Day Movers 7/7: RDN, APPX, IGLD, MPG Higher; VRTU, ININ, FBN, OFIX Lower
- Pre-Open Movers 7/7: APP Pharmaceuticals (APPX) Up on Buyout; Marshall & Ilsley (MI) Lower After Predicting Large Q2 Loss
- Fresenius Acquires APP Pharmaceuticals (APPX) For $23/Share, Plus An Extra $6 If Results are Meet
- APP Pharmaceuticals (APPX) Receives Final Approval for Generic Kytril
APP Pharmaceuticals, Inc. (Nasdaq: APPX) reports Q2 EPS of $0.24, compared to $0.23 in the same quarter last year. Revenues for the quarter were $197.9 million, compared to $159.3 million in Q207.
Sees FY08 revs in the range of $800-$820 million and EPS of $0.85-$0.95.
APP Pharmaceuticals, Inc. develops, manufactures, and markets injectable pharmaceutical products.
Related Categories
EarningsGuidance
Stocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
